EU-Canada trade talks include "harmful" IP provisions: Teva exec
This article was originally published in SRA
The EU has tabled "harmful" intellectual property measures as part of its discussions under the Canada-EU trade talks, according to Barry Fishman, president and chief executive of Teva Canada.
You may also be interested in...
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
Dr Reddy’s combines forces with the Russian Direct Investment Fund for clinical trials and supply of Sputnik V in India, amid what it views as “very important” data points in early studies of the COVID-19 vaccine.